Works matching IS 14642662 AND DT 2004 AND VI 5 AND IP 5

Results: 13

Effectiveness and tolerability of a once-daily amprenavir/ritonavir-containing highly active antiretroviral therapy regimen in antiretroviral-naïve patients at risk for nonadherence: 48-week results after 24 weeks of directly observed therapy.

Published in:

2004

By:

Jayaweera DT;
Kolber MA;
Brill M;
Tanner T;
Campo R;
Rodriguez A;
Chu H;
Garg V

Publication type:

Journal Article

Delayed progression to AIDS in volunteers treated with long-term HIV-1 Immunogen (REMUNE) therapy in Thailand.

Published in:

2004

By:

Chantratita W;
Sukeepaisarncharoen W;
Chandeying V;
Kulpradist S;
Ayudhtaya BIN;
Rugpao S;
Sirawaraporn W;
Boonshuyar C;
Churdboonchart V

Publication type:

Journal Article

Is the Salk principle still viable for the design of an effective HIV vaccine?

Published in:

HIV Medicine, 2004, v. 5, n. 5, p. 315, doi. 10.1111/j.1468-1293.2004.00229.x

By:

Lundgren, J. D.

Publication type:

Article

Delayed progression to AIDS in volunteers treated with long-term HIV-1 Immunogen (REMUNE®) therapy in Thailand.

Published in:

HIV Medicine, 2004, v. 5, n. 5, p. 317, doi. 10.1111/j.1468-1293.2004.00230.x

By:

Chantratita, W.;
Sukeepaisarncharoen, W.;
Chandeying, V.;
Kulpradist, S.;
Na Ayudhtaya, B. Israngkura;
Rugpao, S.;
Sirawaraporn, W.;
Boonshuyar, C.;
Churdboonchart, V.

Publication type:

Article

Recent changes in the management of primary HIV-1 infection: results from the French PRIMO cohort.

Published in:

HIV Medicine, 2004, v. 5, n. 5, p. 326, doi. 10.1111/j.1468-1293.2004.00231.x

By:

Schiffer, V.;
Deveau, C.;
Meyer, L.;
Iraqui, I.;
Nguyen-Wartel, A.;
Chaix, M.-L.;
Delfraissy, J.-F.;
Rouzioux, C.;
Venet, A.;
Goujard, C.

Publication type:

Article

Lopinavir/ritonavir treatment in HIV antiretroviral-experienced patients: evaluation of risk factors for liver enzyme elevation.

Published in:

HIV Medicine, 2004, v. 5, n. 5, p. 334, doi. 10.1111/j.1468-1293.2004.00232.x

By:

Meraviglia, P.;
Schiavini, M.;
Castagna, A.;
Vigano, P.;
Bini, T.;
Landonio, S.;
Danise, A.;
Moioli, M. C.;
Angeli, E.;
Bongiovanni, M.;
Hasson, H.;
Duca, P.;
Cargnel, A.

Publication type:

Article

Resistance profiles and adherence at primary virological failure in three different highly active antiretroviral therapy regimens: analysis of failure rates in a randomized study.

Published in:

HIV Medicine, 2004, v. 5, n. 5, p. 344, doi. 10.1111/j.1468-1293.2004.00233.x

By:

Røge, B. T.;
Barfod, T. S.;
Kirk, O.;
Katzenstein, T. L.;
Obel, N.;
Nielsen, H.;
Pedersen, C.;
Mathiesen, L. R.;
Lundgren, J. D.;
Gerstoft, J.

Publication type:

Article

GENOPHAR: a randomized study of plasma drug measurements in association with genotypic resistance testing and expert advice to optimize therapy in patients failing antiretroviral therapy.

Published in:

HIV Medicine, 2004, v. 5, n. 5, p. 352, doi. 10.1111/j.1468-1293.2004.00234.x

By:

Bossi, P.;
Peytavin, G.;
Ait-Mohand, H.;
Delaugerre, C.;
Ktorza, N.;
Paris, L.;
Bonmarchand, M.;
Cacace, R.;
David, D.-J.;
Simon, A.;
Lamotte, C.;
Marcelin, A.-G.;
Calvez, V.;
Bricaire, F.;
Costagliola, D.;
Katlama, C.

Publication type:

Article

A significant proportion of HIV-infected patients admitted to hospital have immunosuppression as a result of failure of highly active antiretroviral therapy.

Published in:

HIV Medicine, 2004, v. 5, n. 5, p. 360, doi. 10.1111/j.1468-1293.2004.00235.x

By:

Manavi, K.;
McMillan, A.

Publication type:

Article

Effectiveness and tolerability of a once-daily amprenavir/ritonavir-containing highly active antiretroviral therapy regimen in antiretroviral-naïve patients at risk for nonadherence: 48-week results after 24 weeks of directly observed therapy.

Published in:

HIV Medicine, 2004, v. 5, n. 5, p. 364, doi. 10.1111/j.1468-1293.2004.00236.x

By:

Jayaweera, D. T.;
Kolber, M. A.;
Brill, M.;
Tanner, T.;
Campo, R.;
Rodriguez, A.;
Chu, H.-M.;
Garg, V.

Publication type:

Article

Kinetics of lactate metabolism after submaximal ergometric exercise in HIV-infected patients.

Published in:

HIV Medicine, 2004, v. 5, n. 5, p. 371, doi. 10.1111/j.1468-1293.2004.00237.x

By:

Bauer, A.-M.;
Sternfeld, T.;
Horster, S.;
Schunk, M.;
Goebel, F.-D.;
Bogner, J. R.

Publication type:

Article

Clinical features and predictors of survival of AIDS-related non-Hodgkin's lymphoma in a population-based case series in Sydney, Australia.

Published in:

HIV Medicine, 2004, v. 5, n. 5, p. 377, doi. 10.1111/j.1468-1293.2004.00238.x

By:

Robotin, M. C.;
Law, M. G.;
Milliken, S.;
Goldstein, D.;
Garsia, R. J.;
Dolan, G. M.;
Kaldor, J. M.;
Grulich, A. E.

Publication type:

Article

Significance of hepatitis C virus coinfection with persistently normal alanine aminotransferase levels in HIV-1-infected patients.

Published in:

HIV Medicine, 2004, v. 5, n. 5, p. 385, doi. 10.1111/j.1468-1293.2004.00239.x

By:

Fonquernie, L.;
Serfaty, L.;
Charrois, A.;
Wendum, D.;
Lefebvre, B.;
Girard, P. M.;
Meynard, J. L.

Publication type:

Article